Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chorionic gonadotropin subunit beta 7 (CGB7) is a protein encoded by the CGB7 gene, one of several beta subunit family members that form human chorionic gonadotropin (hCG)[1][3]. hCG is a heterodimeric glycoprotein hormone consisting of a common alpha subunit (shared with other glycoprotein hormones) and a unique beta subunit, the latter conferring biological specificity[1][5]. Beta-hCG is crucial for the recognition and maintenance of early pregnancy, stimulating the ovaries to produce steroids needed to sustain gestation[1][3][5]. CGB7, together with other beta subunit genes (CGB3, CGB5, CGB8), is expressed primarily in placental trophoblastic cells, but also displays distinct tissue expression likely due to differences in regulatory sequences such as p53-responsive promoters[2]. Functionally, CGB7 forms part of the hCG hormone that acts through the LHCGR receptor to maintain the corpus luteum and support progesterone synthesis[5]. Levels of the beta-hCG subunit serve as biomarkers in pregnancy and certain malignancies such as choriocarcinoma and germ cell tumors[5]. CGB7 itself is not a therapeutic target per se, but pharmaceuticals utilize the hCG heterodimer containing the CGB7 (or homologous) subunits for reproductive medicine indications[5].
Agonist of luteinizing hormone/choriogonadotropin receptor (LHCGR) when part of the hCG heterodimer, leading to stimulation of corpus luteum, progesterone production, maintaining pregnancy[5]
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chorionic gonadotropin subunit beta 7 (CGB7).